DHG Pharma continues to accompany with the 2026 ENT Scientific Conference, organized annually by the ENT Association of HCM City and Vietnam Southern Province, held in Nha Trang on March 21–22, 2026. The event brought together nearly 800 experts, doctors, and healthcare professionals nationwide, serving as one of the most prestigious forums in the field to update advances in diagnosis, treatment, caring, and professional connections.

For more than a decade, DHG Pharma has consistently accompanied the ENT Association in organizing scientific conferences for doctors, pharmacists, and medical staff, etc affirming its role in promoting knowledge updates and improving treatment outcomes. In 2026, the company continued its support by sponsoring 120 doctors and specialists from across the country to attend the conference, contributing to the dissemination of knowledge, strengthening professional networking, and encouraging the exchange of clinical experience. This reflects DHG Pharma’s commitment to accompanying the medical community not only through products but also through knowledge and practical treatment insights.

The conference brought together leading ENT experts, creating a prestigious academic forum.

DHG Pharma serves as a vital link, connect ENT experts across the country.

In addition, DHG Pharma has been highly regarded by medical experts thanks to internationally certified production system, with manufacturing facilities meeting Japan-GMP and EU-GMP standards, and a portfolio of more than 100 bioequivalent products to original drug. This contributes to ensuring treatment efficacy and safety, earning increasing trust from doctors nationwide.

Assoc. Prof. Dr. Nguyen Thi Ngoc Dung – President of the Ho Chi Minh City Medical Association, and Prof. Dr. Tran Phan Chung Thuy – President of the Vietnam ENT Association, visited the DHG Pharma booth and discussed treatment solutions in clinical practice.

From treatment guidelines to real-world choices: The role of active ingredients in ENT and respiratory care

Amid the growing challenge of antibiotic resistance, respiratory and ENT infections remain a major concern in clinical practice. This was also a key highlight at the conference, featuring 71 scientific reports from 75 leading experts across 10 parallel sessions.

According to updated guidelines, Amoxicillin/Clavulanic Acid continues to be the first-line antibiotic in treating acute rhinosinusitis and acute otitis media, especially against beta-lactamase–producing bacterial strains. As a result, high-standard, bioequivalent products such as Klamentin by DHG Pharma are increasingly trusted by doctors.

In the field of allergic diseases, Fexofenadine remains the preferred choice thanks to its strong efficacy and minimal sedative effect. Products like Telfor by DHG Pharma help control symptoms and improve patients’ quality of life.

Dr. Specialist Level II. Luu Thi Thu Thuy highlighted DHG Pharma’s dedication to connecting and sharing medical knowledge among professionals.

Sharing at the conference, Dr. Specialist Level II. Luu Thi Thu Thuy – Head of the Outpatient Department, Khanh Hoa General Hospital – stated: “The conference is a very meaningful occasion for doctors to update their knowledge and the latest treatment guidelines. DHG Pharma’s companionship has effectively supported clinical practice, giving patients greater opportunities for better treatment.”

M. Dr. Specialist Level II. Tran Tien Phong highly appreciated the products from DHG Pharma.

Meanwhile, M. Dr. Specialist Level II. Tran Tien Phong – Head of the ENT Department at Bac Thang Long Hospital, Hanoi – emphasized: “DHG Pharma is one of the country’s leading and most reputable pharmaceutical companies. Products such as Klamentin and Telfor demonstrate strong efficacy, minimal side effects, and are increasingly trusted by doctors in clinical practice.”

DHG Pharma’s portfolio is increasingly recognized and trusted by doctors in managing ENT and respiratory conditions.

Prof. Dr. Pham Kien Huu – President of the Ho Chi Minh City ENT Association (far left) – presented a letter of appreciation to the representative of DHG Pharma (center).

Closing the conference, DHG Pharma once again reaffirmed its role as a trusted partner of the medical community, contributing to the integration of scientific advances into clinical practice. This reflects the company’s strong commitment to its long-term mission: For a more beautiful and healthier life.